A phase III, open-label, randomized study of atezolizumab in combination with carboplatin plus paclitaxel plus bevacizumab compared with pemetrexed plus cisplatin or carboplatin with stage IV non-squamous non-small cell lung cancer (NSCLC) with activating EGFR mutation or ALK translocation (ATLAS Trial).

상세 보기

Citations

WEB OF SCIENCE

1

제목: A phase III, open-label, randomized study of atezolizumab in combination with carboplatin plus paclitaxel plus bevacizumab compared with pemetrexed plus cisplatin or carboplatin with stage IV non-squamous non-small cell lung cancer (NSCLC) with activating EGFR mutation or ALK translocation (ATLAS Trial).

저자: Park, Sehhoon; Lee, Yun-Gyoo; Park, Ji Hyun; Lee, Gyeong-Won; Kang, Eun Joo; Choi, Yoon Ji; Shin, SeongHoon; Han, Ji-Youn; Lee, Suee; Kim, YuJung; Kim, Tae Min; Kim, Sang-We; Shim, Byoung Yong; Cho, Jinhyun; Kim, Hye Sook; Park, Sang Gon; Lee, Ki Hyeong; Kim, Ilhwan; Ahn, Myung-Ju